AMAG Pharma (AMAG) Tops Q3 EPS by 31c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Selling, general and administrative expenses: 57.22M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Selling, general and administrative expenses: 57.22M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of $1.81, $0.31 better than the analyst estimate of $1.50. Revenue for the quarter came in at $143.8 million versus the consensus estimate of $141.48 million.
GUIDANCE:
AMAG Pharma sees FY2016 revenue of $523-553 million, versus prior guidance of $503-553 million and the consensus of $543.0 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
